🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

68+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 68 recruiting trials for “Diffuse cutaneous systemic sclerosis

Phase 1, PHASE2RecruitingNCT06058091

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

👨‍⚕️ Jing Wang, Jiangsu Renocell Biotech Company📍 1 site📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT05869955

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 54 sites📅 Started Sep 2023View details ↗
Phase 2, PHASE3RecruitingNCT05878717

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

🏥 GlaxoSmithKline📍 131 sites📅 Started Sep 2023View details ↗
Enrolling by InvitationNCT06847750

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

🏥 The Hospital for Sick Children📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT04789850

Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis

👨‍⚕️ Luc Mouthon, MD-PhD, Assistance Publique - Hôpitaux de Paris📍 46 sites📅 Started Feb 2023View details ↗
RecruitingNCT05482607

Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

👨‍⚕️ Paul Decker, MD, CHU NANCY📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05505617

Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

👨‍⚕️ Holger Dressel, Prof, University of Zurich📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

🏥 University Hospital, Brest📍 1 site📅 Started Oct 2022View details ↗
Phase 1RecruitingNCT05016804

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

👨‍⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 2 sites📅 Started Jul 2022View details ↗
Phase 2, PHASE3RecruitingNCT05098704

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

👨‍⚕️ Marie-Elise TRUCHETET, Prof, University Hospital, Bordeaux📍 10 sites📅 Started Jun 2022View details ↗
RecruitingNCT05273138

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

👨‍⚕️ David Launay, MD,PhD, University Hospital, Lille📍 1 site📅 Started Jun 2022View details ↗
Enrolling by InvitationNCT05108857

PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9

👨‍⚕️ Anne Roivainen, Turku University Hospital, Turku PET Centre📍 1 site📅 Started Nov 2021View details ↗
NARecruitingNCT04917705

Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Nov 2021View details ↗
Phase 1, PHASE2RecruitingNCT03211793

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

👨‍⚕️ Marianne Verhaar, MD, PhD, UMC Utrecht📍 1 site📅 Started Oct 2021View details ↗
Phase 2RecruitingNCT04797286

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

👨‍⚕️ Stephen Mathai, MD, Johns Hopkins University📍 2 sites📅 Started Sep 2021View details ↗
NARecruitingNCT04627857

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Jul 2021View details ↗
RecruitingNCT04319120

Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma

🏥 University Hospital, Limoges📍 3 sites📅 Started Dec 2020View details ↗
NAEnrolling by InvitationNCT04875078

UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma

🏥 University of Utah📍 1 site📅 Started Dec 2020View details ↗
Phase 2RecruitingNCT04356755

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

👨‍⚕️ Grégory PUGNET, MD, PHD📍 7 sites📅 Started Sep 2020View details ↗
RecruitingNCT04095351

Connective Tissue Diseases and Lung Manifestations

👨‍⚕️ Judith Löffler-Ragg, Prof. MD, Medical University Innsbruck, Department Internal Medicine📍 1 site📅 Started Dec 2019View details ↗
← PreviousPage 3 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →